{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:57:22Z","timestamp":1780581442627,"version":"3.54.1"},"reference-count":29,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Introduction: Chronic inflammation in axial spondyloarthritis (axSpA) promotes osteoclast formation and bone resorption, leading to osteoporosis and an increased risk of fragility fractures. Osteoporotic fractures significantly impact the quality of life in patients with axSpA. While the Fracture Risk Assessment Tool (FRAX) is widely used to evaluate fracture risk, data on FRAX-based fracture risk assessment in axSpA, particularly in German patients, are limited. Objective: The primary objective of this study was to assess the prevalence of low bone mineral density (BMD) and fracture risk using FRAX for major osteoporotic fractures (MOF) and hip fractures (HF) in German patients with axSpA. Secondary objectives were to compare FRAX scores and BMD between genders and between patients with and without previous fractures, and to identify which FRAX parameters were most frequently abnormal. Materials and Methods: This retrospective study analyzed demographic and clinical data, along with DXA-measured BMD, T-scores and Z-scores of the lumbar spine and femoral neck in 58 axSpA patients aged 43\u201381 years from routine clinical practice. Calculations for MOF and HF were performed using the FRAX model for Germany. Low BMD was defined as a T-score &lt; \u22121 SD or a Z-score &lt; \u22122 SD. Statistical analyses included independent t-tests and chi-square tests. Results: The mean age of patients was 65 years with a mean BMI of 29.5 kg\/m2. The prevalence of low BMD was 44.8% at the lumbar spine and 60.4% at the femoral neck. Overall, 10 (17.2%) patients reported previous fractures of the spine, forearm, hip, or shoulder. Female patients had higher FRAX scores for MOF (8.2%) than males (6.8%, p = 0.02), while male patients had higher FRAX scores for HF (2.8% vs. 2%, p = 0.04). There was no significant difference in BMD between patients with or without a history of fracture. However, patients with previous fractures had significantly higher FRAX scores for MOF (10.2%) compared to those without fractures (7.3%, p = 0.030); the difference in HF scores was not statistically significant (3.5% vs. 2%, p = 0.056). Conclusions: This study highlights the elevated fracture risk in axSpA patients assessed with FRAX. In this cohort, BMD alone was not associated with fracture history, suggesting that other factors\u2014such as age, sex, glucocorticoid exposure, and prior fractures\u2014may play a more prominent role. FRAX provides a valuable tool for evaluating fracture risk in axSpA, emphasizing the importance of a comprehensive assessment that incorporates both clinical risk factors and BMD.<\/jats:p>","DOI":"10.3390\/life16030439","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:06:52Z","timestamp":1773054412000},"page":"439","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of Low Bone Density and Fracture Risk Assessed with the FRAX Tool in German Patients with Axial Spondyloarthritis: A Cross-Sectional Study"],"prefix":"10.3390","volume":"16","author":[{"given":"Elena","family":"Bischoff","sequence":"first","affiliation":[{"name":"Rheumazentrum Ruhrgebiet Herne, Ruhr-Universit\u00e4t Bochum, 44649 Herne, Germany"},{"name":"Department of Health Care, Trakia University, 6000 Stara Zagora, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Sewerin","sequence":"additional","affiliation":[{"name":"Rheumazentrum Ruhrgebiet Herne, Ruhr-Universit\u00e4t Bochum, 44649 Herne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"B\u00fchring","sequence":"additional","affiliation":[{"name":"Bergisches Rheuma-Zentrum, Cellitinnen Krankenhaus St. Josef, 42105 Wuppertal, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Kirilov","sequence":"additional","affiliation":[{"name":"Institute of Medical Informatics, Heidelberg University Hospital, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[{"name":"Rheumazentrum Ruhrgebiet Herne, Ruhr-Universit\u00e4t Bochum, 44649 Herne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref_1","unstructured":"(2024, September 11). Available online: https:\/\/www.osteoporosis.foundation\/patients\/about-osteoporosis\/risk-factors."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40618-023-02219-9","article-title":"An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis","volume":"47","author":"Schini","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.afos.2019.12.002","article-title":"The diversity of Fracture Risk Assessment Tool (FRAX)-based intervention thresholds in Asia","volume":"5","author":"Lekamwasam","year":"2019","journal-title":"Osteoporos. Sarcopenia"},{"key":"ref_4","first-page":"40","article-title":"FRAX Prediction with and Without Bone Mineral Density Testing","volume":"34","author":"Simpkins","year":"2017","journal-title":"Fed. Pract."},{"key":"ref_5","unstructured":"(2024, September 11). Available online: https:\/\/www.nogg.org.uk\/full-guideline\/section-4-intervention-thresholds-and-strategy."},{"key":"ref_6","first-page":"1235","article-title":"Assessment of fracture risk in patients with spondyloarthritis using the FRAX scores","volume":"97","author":"Henchiri","year":"2019","journal-title":"Tunis. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2022-eular.4807","article-title":"AB0870 ASSESSMENT OF FRACTURE RISK IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS","volume":"81","author":"Ferjani","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"keae163.203","DOI":"10.1093\/rheumatology\/keae163.203","article-title":"P164 Fracture risk in axial spondyloarthritis: A retrospective analysis of the use of the Fracture Risk Assessment Tool in a cohort of affected patients","volume":"63","author":"Mulkerrin","year":"2024","journal-title":"Rheumatology"},{"key":"ref_9","first-page":"16","article-title":"Assessment of Fracture Risk and its Predictors in Patients with Axial","volume":"21","author":"Singh","year":"2020","journal-title":"JIACM"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/BOR.0000000000000449","article-title":"Inflammation in bone physiology and pathology","volume":"30","author":"Adamopoulos","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_12","unstructured":"Feingold, K.R., Anawalt, B., Blackman, M.R., Chrousos, G., Corpas, E., Heder, W.W., Dhatariya, K., Dungan, K., Hamilton, E., and Hofland, J. (2025, January 02). The Epidemiology and Pathogenesis of Osteoporosis, Endotext [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279134\/."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00198-010-1319-x","article-title":"Osteoporosis in inflammatory joint diseases","volume":"22","author":"Roux","year":"2011","journal-title":"Osteoporos. Int."},{"key":"ref_14","unstructured":"Porter, J.L., and Varacallo, M. (2025, January 02). Osteoporosis, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441901\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e000052","DOI":"10.1136\/rmdopen-2015-000052","article-title":"Inflammation bone loss and fracture risk in spondyloarthritis","volume":"1","author":"Briot","year":"2015","journal-title":"RMD Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000516132","article-title":"Retrospective Diagnosis of Ankylosing Spondylitis after Spinal Fractures: A Review of 3 Cases and Clinical Implication","volume":"4","author":"Farooque","year":"2021","journal-title":"Case Rep. Orthop. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13075-015-0809-9","article-title":"The prevalence of vertebral fractures in spondyloarthritis: Relation to disease characteristics, bone mineral density, syndesmophytes and history of back pain and trauma","volume":"17","author":"Geusens","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1007\/s11606-021-07241-2","article-title":"Ankylosing Spondylitis and the Risk of Hip Fractures: A Matched Cohort Study","volume":"37","author":"Tsur","year":"2022","journal-title":"J. Gen. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/a-1977-4413","article-title":"Discrepancies Between Osteoporotic Fracture Evaluations in Men Based on German (DVO) Osteoporosis Guidelines or the FRAX Score","volume":"131","author":"Witzel","year":"2023","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e250048","DOI":"10.1530\/EC-25-0048","article-title":"German DVO risk score identified more patients requiring treatment compared to FRAX","volume":"14","author":"Frank","year":"2025","journal-title":"Endocr. Connect."},{"key":"ref_21","first-page":"59","article-title":"Fracture risk and associated factors in elderly patients with ankylosing spondylitis","volume":"13","author":"Candemir","year":"2021","journal-title":"J. Turk. Soc. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semarthrit.2017.12.001","article-title":"Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: A systematic review and meta-analysis","volume":"48","author":"Ramirez","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kim, J.W., Park, S., Jung, J.Y., Kim, H.A., Kwon, S.R., Choi, S.T., Kim, S.S., Kim, S.H., and Suh, C.H. (2022). Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102830"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1007\/s00198-017-4189-7","article-title":"Inflammatory diseases and bone fragility","volume":"28","author":"Briot","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ajeganova, S., Andersson, M., Forslind, K., Gjertsson, I., Nyh\u00e4ll-W\u00e5hlin, B.M., Svensson, B., and Hafstr\u00f6m, I. (2023). Long-term fracture risk in rheumatoid arthritis: Impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years. BMC Rheumatol., 7.","DOI":"10.1186\/s41927-023-00347-6"},{"key":"ref_26","first-page":"100369","article-title":"Correlation study of multiple inflammatory indices and vertebral compression fracture: A cross-sectional study","volume":"37","author":"Fu","year":"2024","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar3833","article-title":"Osteoporosis in ankylosing spondylitis\u2014Prevalence, risk factors and methods of assessment","volume":"14","author":"Klingberg","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/annrheumdis-2020-eular.1570","article-title":"SAT0449 SPONDYLOARTHRITIS AND FRACTURE RISK: DOES DXA REALLY HAVE AN IMPACT IN THE RISK OF FRACTURE ESTIMATED BY FRAX?","volume":"79","author":"Garcia","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/annrheumdis-2024-eular.5626","article-title":"AB0307 USE OF FRAX AND DEFRA TOOLS FOR BONE FRACTURE RISK ASSESSMENT IN AXIAL SPONDYLOARTHRITIS AND AXIAL PSORIATIC ARTHRITIS: A CROSS-SECTIONAL STUDY","volume":"83","author":"Iacovantuono","year":"2024","journal-title":"Ann. Rheum. Dis."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/3\/439\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:20:27Z","timestamp":1773055227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/3\/439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["life16030439"],"URL":"https:\/\/doi.org\/10.3390\/life16030439","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}